<DOC>
	<DOCNO>NCT02807779</DOCNO>
	<brief_summary>This prospective , multicenter , randomize trial determine mechanism vascular healing . The study evaluate subject peripheral artery disease ( PAD ) require endovascular intervention femoro-popliteal ( SFA ) artery restore blood flow leg .</brief_summary>
	<brief_title>Intima Versus Adventitia Drug Delivery Elucidate Mechanisms Restenosis : Magnetic Resonance Imaging</brief_title>
	<detailed_description>Peripheral artery disease ( PAD ) affect least 12 million Americans annually half million patient undergoing endovascular surgical revascularization procedure order treat disease . Unfortunately , two-thirds patient still blockages leg artery , even procedure . Advances Magnetic resonance imaging ( MRI ) offer promise understanding mechanism failure insight vessel wall composition , remodel , inflammation . Restenosis know relationship inflammation . Advances micro-catheter technology offer ability deliver anti-inflammatory medication Dexamethasone ( DEX ) directly adventitia advance drug delivery balloon surface deliver paclitaxel intima artery . This study aim investigate patient-specific parameter affect angioplasty outcome , DEX biological effect vessel wall , effect reduction inflammation .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Screening : 1 . Male nonpregnant female ≥ 35 year age 2 . Atherosclerotic , infrainguinal PAD 3 . Rutherford Clinical Category 26 4 . Stenosis detect radiology clinician opinion reason PAD symptom 5 . Patient willing provide inform consent comply require follow visit , test schedule , medication regimen Procedural Criteria : 1 . Successful angioplasty target lesion portion target lesion define ≤30 % residual lumen stenosis compare adjacent nondiseased lumen diameter , without flowlimiting dissection 2 . De novo atherosclerotic lesion qualify angioplasty 3 . &gt; 50 % diameter stenosis superficial femoral and/or popliteal artery ( profunda tibioperoneal trunk ) 4 . Reference vessel diameter ≥3 mm ≤ 8mm 5 . Successful wire cross lesion 6 . A patent artery proximal index lesion . Concomitant inflow procedure include open femoral artery endarterectomy stenting iliac artery permissible . Screening Criteria : 1 . Any contraindication receive MRI 2 . Pregnant , nursing , plan become pregnant &lt; 2yrs 3 . Life expectancy &lt; 1 yr 4 . History solid organ transplantation 5 . Patient actively participate another investigational device drug study 6 . History hemorrhagic stroke within 3 month 7 . Previous plan surgical interventional procedure within 30 day index procedure 8 . Chronic renal insufficiency eGFR &lt; 45 9 . Prior bypass surgery , stenting , atherectomy angioplasty target lesion 10 . Inability take require study medication 11 . Contraindication know hypersensitivity dexamethasone sodium phosphate , contrast medium , gadolinium , aspirin Plavix 12 . Systemic fungal infection 13 . Acute limb ischemia 14 . Prior participation index limb current study ( contralateral treatment allow ) 15 . Patient receive longterm oral steroid unrelated condition . This include inhaled steroid bronchial disease . Procedural Criteria : 1 . Lesions extend trifurcation profunda . Note outflow treat concomitantly . Similarly common femoral artery treat concomitantly either open endarterectomy patch angioplasty endovascular method . However index lesion contiguous either CFA trifurcation . 2 . Circumferential calcification index lesion , judgment investigator would prevent penetration microinfusion catheter needle vessel wall 3 . Inadequate distal outflow define absence least one patent tibial artery ( lesion &gt; 50 % stenosis ) flow foot . The outflow vessel establish time primary treatment 4 . Use adjunctive therapy angioplasty . The Chocolate balloon score balloon allow however stay reference diameter .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>angioplasty</keyword>
	<keyword>peripheral artery disease</keyword>
	<keyword>peripheral vascular disease</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>balloon angioplasty</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>drug coat balloon</keyword>
	<keyword>paclitaxel</keyword>
	<keyword>walk</keyword>
	<keyword>claudication</keyword>
</DOC>